These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 2465958

  • 21. Clinical evaluation of plasma abnormal prothrombin (PIVKA-II) in patients with hepatocellular carcinoma.
    Fujiyama S, Morishita T, Sagara K, Sato T, Motohara K, Matsuda I.
    Hepatogastroenterology; 1986 Oct; 33(5):201-5. PubMed ID: 2433199
    [Abstract] [Full Text] [Related]

  • 22. Prevalence of subclinical vitamin K deficiency in cholestatic liver disease.
    Strople J, Lovell G, Heubi J.
    J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):78-84. PubMed ID: 19502999
    [Abstract] [Full Text] [Related]

  • 23. Acarboxy prothrombin (PIVKA II) as a tumour marker for hepatocellular carcinoma and other liver diseases.
    Mohamedein A, Yousif-Kadaru AG, Ahmed SA, Saida H, Zaki ZA, Eldin, Fedail SS.
    East Afr Med J; 1995 Sep; 72(9):584-7. PubMed ID: 7498046
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Clinical use of a test for determination of coagulation factors II, X and VII].
    Cascino A, Cangiano C, Attili AF.
    Minerva Med; 1975 Aug 29; 66(55):2743-9. PubMed ID: 1161171
    [Abstract] [Full Text] [Related]

  • 27. Disseminated intravascular coagulation (DIC).
    Mammen EF.
    Clin Lab Sci; 2000 Aug 29; 13(4):239-45. PubMed ID: 11586511
    [Abstract] [Full Text] [Related]

  • 28. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
    Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Mori Y, Deguchi K, Shiku H.
    Pol J Pharmacol; 1996 Aug 29; 48(2):225-8. PubMed ID: 9112656
    [Abstract] [Full Text] [Related]

  • 29. PIVKA-II during perioperative period in patients with hepato-biliary-pancreatic diseases.
    Kanazumi N, Takeda S, Inoue S, Ohshima K, Sugimoto H, Kaneko T, Watanabe K, Nakao A.
    Hepatogastroenterology; 2000 Aug 29; 47(36):1695-9. PubMed ID: 11149034
    [Abstract] [Full Text] [Related]

  • 30. [Prothrombin time and its standardization: a potentiality to introduce INR method in criteria for disseminated intravascular coagulation].
    Kagawa K, Fukutake K.
    Rinsho Byori; 2002 Mar 29; 50(3):277-82. PubMed ID: 11985056
    [Abstract] [Full Text] [Related]

  • 31. [The relationship between postoperative prognosis and positivity of PIVKA-II in patients with hepatocellular carcinoma].
    Sakon M, Monden M, Goto M, Kanai T, Umeshita K, Ukei T, Mori T.
    Nihon Geka Gakkai Zasshi; 1992 Aug 29; 93(8):827-32. PubMed ID: 1331743
    [Abstract] [Full Text] [Related]

  • 32. [New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers].
    Koike K, Fujimaki M.
    Nihon Rinsho; 1993 Jan 29; 51(1):37-42. PubMed ID: 8433526
    [Abstract] [Full Text] [Related]

  • 33. [Clinical usefulness of plasma PIVKA-II assay and its limitations in patients with hepatocellular carcinoma].
    Fujiyama S, Morishita T, Shibata J, Sato T.
    Gan To Kagaku Ryoho; 1989 Apr 29; 16(4 Pt 2-1):1129-38. PubMed ID: 2471453
    [Abstract] [Full Text] [Related]

  • 34. Precursor prothrombin status in two mother-infant pairs following gestational anticonvulsant therapy.
    Argent AC, Rothberg AD, Pienaar N.
    Pediatr Pharmacol (New York); 1984 Apr 29; 4(3):183-7. PubMed ID: 6493841
    [Abstract] [Full Text] [Related]

  • 35. Acquired coagulation disorders.
    Prentice CR.
    Clin Haematol; 1985 Jun 29; 14(2):413-42. PubMed ID: 3899441
    [Abstract] [Full Text] [Related]

  • 36. Factor II related antigen and antithrombin III levels as indicators of liver failure in consumption coagulopathy.
    Sié P, Letrenne E, Caranobe C, Genestal M, Cathala B, Boneu B.
    Thromb Haemost; 1982 Jun 28; 47(3):218-20. PubMed ID: 6810490
    [Abstract] [Full Text] [Related]

  • 37. D-dimer test: diagnostic role in clinical and sub-clinical DIC.
    Saxena R, Gupta PK, Ahmed R, Batra V, Kumar S.
    Indian J Pathol Microbiol; 2003 Jul 28; 46(3):425-6. PubMed ID: 15025290
    [Abstract] [Full Text] [Related]

  • 38. Partially carboxylated prothrombins. I. Comparison of activation properties and purification of 1- and 0-carboxyglutamyl variants.
    Malhotra OP.
    Biochim Biophys Acta; 1982 Apr 03; 702(2):178-84. PubMed ID: 6177345
    [Abstract] [Full Text] [Related]

  • 39. The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants.
    Moore GW, Smith MP, Savidge GF.
    Blood Coagul Fibrinolysis; 2003 Apr 03; 14(3):307-12. PubMed ID: 12695757
    [Abstract] [Full Text] [Related]

  • 40. Preparation of recombinant alpha-thrombin: high-level expression of recombinant human prethrombin-2 and its activation by recombinant ecarin.
    Yonemura H, Imamura T, Soejima K, Nakahara Y, Morikawa W, Ushio Y, Kamachi Y, Nakatake H, Sugawara K, Nakagaki T, Nozaki C.
    J Biochem; 2004 May 03; 135(5):577-82. PubMed ID: 15173195
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.